Ticker
TNXPCompany Name
TONIX PHARMACEUTICALS HOLDING CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 187.36M | $ 5.99M | 3.19% |
3/31/2025 | $ 192.87M | $ 8.14M | 4.22% |
12/31/2024 | $ 162.89M | $ 8.41M | 5.16% |
9/30/2024 | $ 94.99M | $ 7.93M | 8.35% |
6/30/2024 | $ 70.31M | $ 9.46M | 13.45% |
3/31/2024 | $ 135.34M | $ 12.35M | 9.13% |
12/31/2023 | $ 154.46M | $ 13.64M | 8.83% |
9/30/2023 | $ 139.28M | $ 13.32M | 9.56% |
6/30/2023 | $ 159.74M | $ 13.7M | 8.58% |
3/31/2023 | $ 179.09M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for TONIX PHARMACEUTICALS HOLDING CORP is calculated as follows: Inventory [ $ 0 ] / Assets [ $ 67.62M ]
(=) Inv. to Assets [ 0% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.08% |
median | 0% |
std | 11.11% |